DARE-HRT1

· Daré Bioscience, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for DARE-HRT1, covering 2024-10-15 to 2024-10-31. Get the full timeline:

Most recent: Clinical Trial Update: Study of DARE-HRT1 Over 12 Weeks in Healthy PostMenopausal Women [Phase 1, Phase 2]